![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Anemia, Hemolytic, Congenital - 694 Studies Found
Terminated |
: Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study : Sickle Cell Anemia : 2014-02-04 : Drug: Hydroxyurea Other Name: Hydrea |
Recruiting |
: Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia : Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) : 2013-10-08 :
|
Withdrawn |
: Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis :
|
Recruiting |
: Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study :
: 2013-02-18 |
Recruiting |
: A Phase II Trial of Regadenoson in Sickle Cell Anemia : Sickle Cell Anemia : 2013-02-07 :
|
Completed |
: The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia : Sickle Cell Anemia : 2012-10-03 :
|
Recruiting |
: Microvascular Blood Flow in Sickle Cell Anemia :
: 2012-03-28 :
|
Recruiting |
: Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia : Sickle Cell Anemia : 2012-03-13 |
Completed |
: Carbon Monoxide Levels and Sickle Cell Disease Severity :
|
Terminated |
: Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE) : Sickle Cell Anemia : 2012-02-06 : Drug: Hydroxyurea Hydroxyurea will be administered once daily, in either capsule form (300mg, 400mg, or |